12:00 AM
Aug 07, 2000
 |  BC Week In Review  |  Company News  |  Other News

Texas Biotech autoimmune/inflammation news

TXB formed Revotar Biopharmaceuticals AG (Berlin, Germany) as a majority owned subsidiary to discover and develop...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >